UBS AG - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2014$15,000
-34.8%
3,081
-38.1%
0.00%
Q2 2014$23,000
+21.1%
4,981
+23.5%
0.00%
Q1 2014$19,000
-13.6%
4,032
-8.7%
0.00%
Q4 2013$22,000
+4.8%
4,415
-3.3%
0.00%
Q3 2013$21,000
-70.4%
4,564
-67.1%
0.00%
Q2 2013$71,00013,8720.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2014
NameSharesValueWeighting ↓
Sterling Financial Planning, Inc. 22,031$46,0000.03%
BERKSHIRE ASSET MANAGEMENT LLC/PA 189,048$392,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$595,0000.01%
Renaissance Technologies 622,228$1,291,0000.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$390,0000.00%
Oakworth Capital, Inc. 3,052$6,0000.00%
BlackRock Inc. 140,248$292,0000.00%
Citadel Advisors 32,300$67,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,900$60,0000.00%
TWO SIGMA ADVISERS, LP 34,592$72,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders